|
1 |
Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines
Sol-Rim Jeon, Jae-Wook Lee, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho, Dae-Chul Jeong
Blood Res.2015;50(1):33-39. Published online 2015 March 24
DOI: http://dx.doi.org/10.5045/br.2015.50.1.33
|
|
2 |
Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
Jun Ho Jang, Je-Hwan Lee, Sung-Soo Yoon, Deog-Yeon Jo, Hyeoung-Joon Kim, Jooseop Chung, Jong Wook Lee
|
|
3 |
Effects of oral iron chelator deferasirox on human malignant lymphoma cells
Jong Gwon Choi, Jung-Lim Kim, Joohee Park, Soonwook Lee, Seh Jong Park, Jun Suk Kim, Chul Won Choi
Korean J Hematol.2012;47(3):194-201. Published online 2012 September 25
DOI: http://dx.doi.org/10.5045/kjh.2012.47.3.194
|
|
4 |
Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma
Soo Jin Bae, Christine Kang, Ki Woong Sung, Hee Won Chueh, Meong Hi Son, Soo Hyun Lee, Keon Hee Yoo, Hong Hoe Koo
|
|
5 |
Comparison of Immune Responses Induced by Deferoxamine and Deferasirox
Yeong Suk Jung, E Young Bae, Nack Gyun Chung, Bin Cho, Hack Ki Kim, Chang Ki Min, Chi Wha Han, Ho Shik Kim, Dae Chul Jeong
Korean J Hematol.2008;43(3):150-158. Published online 2008 September 19
DOI: http://dx.doi.org/10.5045/kjh.2008.43.3.150
|
|
6 |
Economic Evaluation of Iron Chelation Agents: Oral Deferasirox versus Infusional Deferoxamine
Jin Hyun Kim, Youn Hee Kim
|
|
7 |
Acute Tubulointerstitial Nephritis Induced by Deferasirox following Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia
Jae Woong Min, Seung Jae Hwang, Yeon Jung Lim, Young Ho Lee
|
|